Backed by real-world outcomes and peer-reviewed science.

Hundreds of treatments, peer-reviewed studies, and an unblemished safety profile.

1200+

Successful cases

Across Hong Kong, China & Taiwan.

500+

Documented treatments

Tracked, real-world outcomes.

85%

Dog osteoarthritis

Pain reduction (Frontiers in Veterinary Science).

Adverse events

An unblemished safety profile to date.

Featured publication

Peer-reviewed science behind the platform.

A double-blinded, randomized, placebo-controlled study — one of several peer-reviewed papers behind CuraCell.

Frontiers in Veterinary Science · 2020

Intra-articular Allogeneic Adipose-Derived MSCs Reduce Pain and Lameness in Dogs With Hip Osteoarthritis

The flagship pilot study supporting CuraCell's allogeneic MSC therapy in dogs.

Maki CB, Beck A, Wallis CCC, Choo J, Ramos T, Tong R, Borjesson DL, Izadyar F.

A double-blinded, randomized, placebo-controlled pilot study demonstrating significant pain reduction and improved mobility in dogs with hip osteoarthritis.

Front Vet Sci 2020;7:570 · doi:10.3389/fvets.2020.00570 · PMID: 33110913

Selected publications

Supporting peer-reviewed literature.

A sample of published work from the CuraCell team and its scientific advisors.

A researcher examining cell samples under a microscope

PLOS ONE · 2019

PDE4D, miR-203 & Cytokines in Canine Atopic Dermatitis

Koury J, … Izadyar F, … Hao J. PLoS One 2019;14(6):e0218670.

Vet Res Commun · 2022

Double-blinded Evaluation of Adipose-Derived MSCs in Canine AD

Kaur G, … Izadyar F, … Hao J. Vet Res Commun 2022;46(1):251-260.

Book Chapter · 2017

Cell-based Therapy in Veterinary Medicine

Maki C, Ramos T, Izadyar F. Frontiers in Stem Cell & Regenerative Medicine, Vol. 4.

Cell Stem Cell · 2008

MSC-mediated Immunosuppression via Chemokines & Nitric Oxide

Ren G, … Shi Y. Cell Stem Cell 2008;2(2):141-50.

Nature Immunology · 2014

Plasticity of Mesenchymal Stem Cells in Immunomodulation

Wang Y, … Shi Y. Nat Immunol 2014;15(11):1009-16.

J Tissue Eng Regen Med · 2009

Adipose Stem Cell Side Population in the Mouse

Ramos TV, … Izadyar F. J Tissue Eng Regen Med 2009;3(6):430-41.

Safety

An unblemished safety profile.

Across 500+ documented treatments delivered in Hong Kong, China and Taiwan, CuraCell has recorded zero adverse safety events. The allogeneic, donor-derived source carries minimal rejection risk, and there is no known long-term toxicity to date.

Every batch is quality-controlled and manufactured to a standardized therapeutic dose, giving veterinarians confidence in a consistent, repeatable treatment.

An owner walking a happy senior dog — a good outcome

See the science in action.

Find a CuraCell clinic, or explore a clinical partnership.

Find a clinic → How it works